Scott Newsome

Research output

Research output per year 2007 2015 2016 2019 2020 2021 2022 2023 2024

• 118 Article
• 16 Review article
• 5 Letter
• 4 Comment/debate
• 7 More
  • 2 Chapter
  • 2 Conference contribution
  • 2 Short survey
  • 1 Editorial

Research output per year

Research output per year

Search results

• 2024

  A 42-Year-Old Woman With Rapidly Expanding White Matter Lesions: From the National Multiple Sclerosis Society Case Conference Proceedings

  Amiola, T. O., Oh, U., Richard, H., Newsome, S. D., Graves, J., Zamvil, S. S. & Goldman, M. D., May 1 2024, In: Neurology(R) neuroimmunology & neuroinflammation. 11, 3, p. e200201

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cocaine 100%
  • Congresses 98%
  • White Matter 90%
  • Multiple Sclerosis 88%
  • Demyelinating Diseases 52%

• Era of COVID-19 in Multiple Sclerosis Care

  Krett, J. D., Salter, A. & Newsome, S. D., Feb 2024, In: Neurologic clinics. 42, 1, p. 319-340 22 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

• Insights for Healthcare Providers on Shared Decision-Making in Multiple Sclerosis: A Narrative Review

  Stoll, S., Costello, K., Newsome, S. D., Schmidt, H., Sullivan, A. B. & Hendin, B., Feb 2024, In: Neurology and Therapy. 13, 1, p. 21-37 17 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Shared Decision Making 100%
  • Multiple Sclerosis 71%
  • Health Personnel 70%
  • Treatment Adherence and Compliance 13%
  • Psychological Practice 11%

• Progressive Encephalomyelopathy in an Older Man: A Case Report From the National Multiple Sclerosis Society Case Conference Proceedings

  Ross, L. A., Lee, J., Carlson, A. K., Conway, D. S., Cohen, J. A., Graves, J., Zamvil, S. S., Newsome, S. D. & Kunchok, A., May 1 2024, In: Neurology(R) neuroimmunology & neuroinflammation. 11, 3, p. e200210

  Research output: Contribution to journal › Article › peer-review

  • Congresses 100%
  • Multiple Sclerosis 89%

• Recognition, Description, and Variability of Spasticity in Individuals With Multiple Sclerosis and Potential Barriers to Clinician-Patient Dialogue: Results From SEEN-MSS, a Large-Scale, Self-Reported Survey

  Thrower, B., Newsome, S. D., Hendin, B., Danese, S., Patterson, J. & Chinnapongse, R., 2024, In: International Journal of MS Care. 26, 2, p. 75-80 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Relapsing White Matter Disease and Subclinical Optic Neuropathy

  O'Neill, K. A., Dugue, A., Abreu, N. J., Balcer, L. J., Branche, M., Galetta, S., Graves, J., Kister, I., Magro, C., Miller, C., Newsome, S. D., Pappas, J., Rucker, J., Steigerwald, C., William, C. M., Zamvil, S. S., Grossman, S. N. & Krupp, L. B., Mar 1 2024, In: Neurology(R) neuroimmunology & neuroinflammation. 11, 2, p. e200194

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Leukoencephalopathies 100%
  • Optic Nerve Diseases 93%
  • Hypesthesia 85%
  • Oligoclonal Bands 53%
  • Plasmapheresis 45%

• Teenager With Recurrent Ataxia, Ophthalmoplegia, and Encephalopathy Associated With Demyelination

  Poisson, K. E., Newsome, S. D., Graves, J., Zamvil, S. S. & Marcus, L. R., Mar 1 2024, In: Neurology(R) neuroimmunology & neuroinflammation. 11, 2, p. e200193

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Ophthalmoplegia 100%
  • Dysarthria 94%
  • Pharyngitis 88%
  • Symptom Flare Up 86%
  • Rituximab 81%
• 2023

  A 28-Year-Old Woman With Left-Sided Weakness and Atypical MRI Lesions: From the National Multiple Sclerosis Society Case Conference Proceedings

  Safadi, A. L., Osborne, B., Chitnis, T., Graves, J. S., Newsome, S. D., Zamvil, S. S., Solomon, I. H. & Shin, R. K., Nov 1 2023, In: Neurology(R) neuroimmunology & neuroinflammation. 10, 6

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Congresses 100%
  • Multiple Sclerosis 89%
  • Immunosuppressive Agents 28%
  • Biopsy 20%
  • Therapeutics 5%

• A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS

  Newsome, S. D., Tian, F., Shoemaker, T., Fitzgerald, K. C., Cassard, S. D., Fiol, J., Snoops, S., Cooper, D. S., Mammen, J. S. R., Bhargava, P., Mowry, E. M. & Calabresi, P. A., Sep 2023, In: Neurotherapeutics. 20, 5, p. 1263-1274 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Triiodothyronine 100%
  • Multiple Sclerosis 78%
  • Safety 51%
  • Remyelination 39%
  • Thyroid Hormones 29%

• Assessment of anti-GAD65-associated cerebellar ataxia with ¹⁸F-FDG cerebellar uptake: ROC analysis

  Sadaghiani, M. S., Roman, S., Wang, Y., Rowe, S. P., Leal, J. P., Newsome, S. D. & Solnes, L. B., Sep 2023, In: Annals of Nuclear Medicine. 37, 9, p. 528-534 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Cerebellar Ataxia 100%
  • Glutamate Decarboxylase 98%
  • Fluorodeoxyglucose F18 84%
  • ROC Curve 68%
  • Cerebellum 45%

• Centripetal Nystagmus, Slow Saccades, Cerebellar Ataxia, and Parkinsonism in a Patient with Anti-GAD65-Associated Stiff Person Syndrome Spectrum Disorder

  Hac, N. E. F., Murphy, O. C., Butala, A. A., Newsome, S. D. & Gold, D. R., Jun 1 2023, In: Journal of Neuro-Ophthalmology. 43, 2, p. 273-276 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Stiff-Person Syndrome 100%
  • Pathologic Nystagmus 89%
  • Cerebellar Ataxia 79%
  • Glutamate Decarboxylase 78%
  • Saccades 74%

• Differential diagnosis of suspected multiple sclerosis: an updated consensus approach

  Solomon, A. J., Arrambide, G., Brownlee, W. J., Flanagan, E. P., Amato, M. P., Amezcua, L., Banwell, B. L., Barkhof, F., Corboy, J. R., Correale, J., Fujihara, K., Graves, J., Harnegie, M. P., Hemmer, B., Lechner-Scott, J., Marrie, R. A., Newsome, S. D., Rocca, M. A., Royal, W., Waubant, E. L., & 2 othersYamout, B. & Cohen, J. A., Aug 2023, In: The Lancet Neurology. 22, 8, p. 750-768 19 p.

  Research output: Contribution to journal › Review article › peer-review

  • Multiple Sclerosis 100%
  • Differential Diagnosis 87%
  • Advisory Committees 15%
  • Diagnostic Errors 13%
  • Clinical Trials 9%

• Expanding clinical profiles and prognostic markers in stiff person syndrome spectrum disorders

  Wang, Y., Hu, C., Aljarallah, S., Reyes Mantilla, M., Mukharesh, L., Simpson, A., Roy, S., Harrison, K., Shoemaker, T., Comisac, M., Balshi, A., Obando, D., Maldonado, D. A. P., Koshorek, J., Snoops, S., Fitzgerald, K. C. & Newsome, S. D., 2023, (Accepted/In press) In: Journal of neurology.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Stiff-Person Syndrome 100%
  • Progressive Encephalomyelitis with Rigidity 93%
  • Brain Stem 42%
  • Age of Onset 30%
  • Walking 27%

• HACA3: A unified approach for multi-site MR image harmonization

  Zuo, L., Liu, Y., Xue, Y., Dewey, B. E., Remedios, S. W., Hays, S. P., Bilgel, M., Mowry, E. M., Newsome, S. D., Calabresi, P. A., Resnick, S. M., Prince, J. L. & Carass, A., Oct 2023, In: Computerized Medical Imaging and Graphics. 109, 102285.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Magnetic resonance 100%
  • Magnetic Resonance Spectroscopy 81%
  • Anatomy 39%
  • Artifacts 34%
  • Imaging techniques 24%

• Impact of COVID-19 on prescribing patterns and treatment selection of disease modifying therapies in multiple sclerosis

  Zaheer, R., Amin, R., Riddick, L. T., Roy, S., Wolff, S., Nathanson, A. & Newsome, S., Mar 2023, In: Multiple Sclerosis and Related Disorders. 71, 104575.

  Research output: Contribution to journal › Article › peer-review

  • Multiple Sclerosis 100%
  • Pandemics 28%
  • Vaccines 27%
  • Therapeutics 18%
  • Prescriptions 11%

• MOG Antibody-Associated Disease and Thymic Hyperplasia: From the National Multiple Sclerosis Society Case Conference Proceedings

  Hurtubise, B., Frohman, E. M., Galetta, S., Balcer, L. J., Frohman, T. C., Lisak, R. P., Newsome, S. D., Graves, J. S., Zamvil, S. S. & Amezcua, L., Mar 14 2023, In: Neurology: Neuroimmunology and NeuroInflammation. 10, 2, e200077.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Thymus Hyperplasia 100%
  • Congresses 63%
  • Multiple Sclerosis 56%
  • Myelin-Oligodendrocyte Glycoprotein 55%
  • Antibodies 35%

• No Evidence of Disease Activity (NEDA) as a Clinical Assessment Tool for Multiple Sclerosis: Clinician and Patient Perspectives [Narrative Review]

  Newsome, S. D., Binns, C., Kaunzner, U. W., Morgan, S. & Halper, J., Dec 2023, In: Neurology and Therapy. 12, 6, p. 1909-1935 27 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Multiple Sclerosis 100%
  • Clinical Decision-Making 11%
  • Therapeutics 9%
  • Health Care Outcome Assessment 7%
  • Clinical Trials 7%

• Prevalence of non-neurological autoantibodies and related comorbidities in stiff person spectrum disorders

  Balshi, A., Taylor, E., Huang, Y., Obando, D., Miles, A., Comisac, M., Wang, Y. & Newsome, S. D., 2023, In: Frontiers in Neurology. 14, 1289460.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Stiff-Person Syndrome 100%
  • Autoantibodies 58%
  • Comorbidity 49%
  • Walking 13%
  • Pernicious Anemia 11%

• Recurrent Optic Neuritis and Perineuritis Followed by an Unexpected Discovery: From the National Multiple Sclerosis Society Case Conference Proceedings

  Maldonado, D. A. P., Lisak, R., Galetta, S., Balcer, L., Varkey, T., Goodman, A., Graves, J., Racke, M., Zamvil, S. S., Newsome, S., Frohman, E. M. & Frohman, T. C., Jan 10 2023, In: Neurology: Neuroimmunology and NeuroInflammation. 10, 1, e200051.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Neuromyelitis Optica 100%
  • Optic Neuritis 94%
  • Mycophenolic Acid 86%
  • Paresthesia 84%
  • Rituximab 80%

• Relapsing Encephalomyelitis After COVID-19 Infection and Vaccination: From the National MS Society Case Conference Proceedings

  Roy, S., Barreras, P., Pardo, C. A., Graves, J. S., Zamvil, S. S. & Newsome, S. D., May 1 2023, In: Neurology(R) neuroimmunology & neuroinflammation. 10, 3

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Encephalomyelitis 100%
  • Severe Acute Respiratory Syndrome 94%
  • Congresses 72%
  • Vaccination 58%
  • Infections 34%

• Respiratory symptoms are common in stiff person syndrome spectrum disorders and are associated with number of body regions involved

  Pimentel Maldonado, D. A., Balshi, A., Hu, C., Fitzgerald, K. C., Koshorek, J., Reyes-Mantilla, M. I., Obando, D., Wang, Y. & Newsome, S. D., Aug 2023, In: European Journal of Neurology. 30, 8, p. 2498-2505 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Stiff-Person Syndrome 100%
  • Body Regions 79%
  • Spirometry 30%
  • Logistic Models 11%
  • Odds Ratio 11%

• Stiff Person Spectrum Disorders—An Update and Outlook on Clinical, Pathophysiological and Treatment Perspectives

  Vlad, B., Wang, Y., Newsome, S. D. & Balint, B., Sep 2023, In: Biomedicines. 11, 9, 2500.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Disorder 100%
  • Hyperekplexia 66%
  • Immunomodulation 44%
  • Movement Disorders 43%
  • Autoantibodies 35%

• The many faces of gastrointestinal dysfunction in stiff person syndrome spectrum disorders

  Koshorek, J., Wang, Y., Maldonado, D. P., Reyes-Mantilla, M. I., Obando, D., Balshi, A., Comisac, M., Pasricha, P. J. & Newsome, S. D., 2023, In: Frontiers in Neurology. 14, 1273256.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Stiff-Person Syndrome 100%
  • Gastrointestinal Transit 11%
  • Constipation 8%
  • Deglutition Disorders 8%
  • Nausea 7%

• Therapeutic plasma exchange in the management of stiff person syndrome spectrum disorders: a case series and review of the literature

  Mercure-Corriveau, N., Roy, S., Hu, C., Crowe, E. P., Zhu, X., Obando, D., Patel, E. U., Tobian, A. A. R., Wang, Y., Bloch, E. M. & Newsome, S. D., Jan 1 2023, In: Therapeutic Advances in Neurological Disorders. 16

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Stiff-Person Syndrome 100%
  • Plasma Exchange 77%
  • Therapeutics 10%
  • Progressive Encephalomyelitis with Rigidity 4%
  • Cerebellar Ataxia 2%

• Trans-Synaptic Degeneration Following Acute Optic Neuritis in Multiple Sclerosis

  Murphy, O. C., Sotirchos, E. S., Kalaitzidis, G., Vasileiou, E., Ehrhardt, H., Lambe, J., Kwakyi, O., Nguyen, J., Zambriczki Lee, A., Button, J., Dewey, B. E., Newsome, S. D., Mowry, E. M., Fitzgerald, K. C., Prince, J. L., Calabresi, P. A. & Saidha, S., Jan 2023, In: Annals of neurology. 93, 1, p. 76-87 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Retrograde Degeneration 100%
  • Optic Neuritis 83%
  • Multiple Sclerosis 58%
  • Gray Matter 51%
  • Atrophy 25%

• Unsupervised Quality Assurance for Brain MR Image Rigid Registration using Latent Shape Representation

  Xue, Y., Zuo, L., Remedios, S. W., Dewey, B. E., Duan, P., Liu, Y., Zhang, R., Newsome, S. D., Mowry, E. M., Carass, A. & Prince, J. L., 2023, Medical Imaging 2023: Image Processing. Colliot, O. & Isgum, I. (eds.). SPIE, 124641G. (Progress in Biomedical Optics and Imaging - Proceedings of SPIE; vol. 12464).

  Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

  • assurance 100%
  • Quality assurance 92%
  • Magnetic Resonance 90%
  • Magnetic resonance 90%
  • brain 82%
• 2022

  Benefits of early treatment with natalizumab: a real-world study

  Ontaneda, D., Mowry, E. M., Newsome, S. D., Naismith, R. T., Nicholas, J., Fisher, E., de Moor, C., Bohn, J., Ho, P. R., Sandrock, A., Rudick, R. & Williams, J. R., Dec 2022, In: Multiple Sclerosis and Related Disorders. 68, 104216.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Natalizumab 100%
  • Multiple Sclerosis 61%
  • Walking Speed 23%
  • Biomedical Technology 12%
  • Therapeutics 11%

• Cognitive and Mood Profiles Among Patients With Stiff Person Syndrome Spectrum Disorders

  Chan, C. K., Pimentel Maldonado, D. A., Wang, Y., Obando, D., Hughes, A. J. & Newsome, S. D., May 27 2022, In: Frontiers in Neurology. 13, 865462.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Stiff-Person Syndrome 100%
  • Verbal Learning 42%
  • Cognitive Dysfunction 39%
  • Psychiatry 23%
  • Anxiety 22%

• Correction to: Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era (Advances in Therapy, (2021), 38, 7, (3550-3588), 10.1007/s12325-021-01761-3)

  Coyle, P. K., Gocke, A., Vignos, M. & Newsome, S. D., Jan 2022, In: Advances in Therapy. 39, 1, p. 822-830 9 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • ozanimod 100%
  • Sphingosine-1-Phosphate Receptors 68%
  • Multiple Sclerosis 43%
  • Vaccination 39%
  • Vaccines 36%

• COVID-19 in the pregnant or postpartum MS patient: Symptoms and outcomes

  Salter, A., Cross, A. H., Cutter, G. R., Fox, R. J., Li, D. K. B., Bebo, B., Halper, J., Kanellis, P., Rammohan, K. & Newsome, S. D., Sep 2022, In: Multiple Sclerosis and Related Disorders. 65, 104028.

  Research output: Contribution to journal › Letter › peer-review

  • Postpartum Period 100%
  • Multiple Sclerosis 92%
  • Propensity Score 22%
  • Registries 16%

• Early treatment responses to peginterferon beta-1a are associated with longer-term clinical outcomes in patients with relapsing-remitting multiple sclerosis: Subgroup analyses of ADVANCE and ATTAIN

  Newsome, S. D., Scott, T. F., Arnold, D. L., Altincatal, A. & Naylor, M. L., Jan 2022, In: Multiple Sclerosis and Related Disorders. 57, 103367.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • peginterferon beta-1a 100%
  • Relapsing-Remitting Multiple Sclerosis 61%
  • Time-to-Treatment 14%
  • Therapeutics 8%
  • Brain 6%

• Leveraging Visual Outcome Measures to Advance Therapy Development in Neuroimmunologic Disorders

  IMSVISUAL, Mar 24 2022, In: Neurology: Neuroimmunology and NeuroInflammation. 9, 2, e1126.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Multiple Sclerosis 100%
  • Neuromyelitis Optica 91%
  • Health Care Outcome Assessment 74%
  • Optical Coherence Tomography 45%
  • Ocular Vision 38%

• Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease

  Barreras, P., Vasileiou, E. S., Filippatou, A. G., Fitzgerald, K. C., Levy, M., Pardo, C. A., Newsome, S. D., Mowry, E. M., Calabresi, P. A. & Sotirchos, E. S., Nov 29 2022, In: Neurology. 99, 22, p. E2504-E2516

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Myelin-Oligodendrocyte Glycoprotein 100%
  • Neuromyelitis Optica 93%
  • Rituximab 75%
  • Immunoglobulin G 52%
  • Safety 40%

• Risk Factors for Infection and Health Impacts of the Coronavirus Disease 2019 (COVID-19) Pandemic in People With Autoimmune Diseases

  Fitzgerald, K. C., Mecoli, C. A., Douglas, M., Harris, S., Aravidis, B., Albayda, J., Sotirchos, E. S., Hoke, A., Orbai, A. M., Petri, M., Christopher-Stine, L., Baer, A. N., Paik, J. J., Adler, B. L., Tiniakou, E., Timlin, H., Bhargava, P., Newsome, S. D., Venkatesan, A., Chaudhry, V., & 14 othersLloyd, T., Pardo, C. A., Stern, B. J., Lazarev, M., Truta, B., Saidha, S., Chen, E. S., Sharp, M., Gilotra, N., Kasper, E. K., Gelber, A. C., Bingham, C. O., Shah, A. A. & Mowry, E. M., Feb 1 2022, In: Clinical Infectious Diseases. 74, 3, p. 427-436 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Coronavirus 100%
  • Pandemics 84%
  • Autoimmune Diseases 68%
  • Health 38%
  • Infections 37%

• Stiff person syndrome spectrum disorders; more than meets the eye

  Newsome, S. D. & Johnson, T., Aug 15 2022, In: Journal of Neuroimmunology. 369, 577915.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Stiff-Person Syndrome 100%
  • Phenotype 25%
  • Signs and Symptoms 18%
  • Direction compound 15%
  • Therapeutics 6%

• Symptom burden, management and treatment goals of people with MS spasticity: Results from SEEN-MSS, a large-scale, self-reported survey

  Newsome, S. D., Thrower, B., Hendin, B., Danese, S., Patterson, J. & Chinnapongse, R., Dec 2022, In: Multiple Sclerosis and Related Disorders. 68, 104376.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Multiple Sclerosis 100%
  • Emotions 89%
  • Self Concept 27%
  • Disease Progression 22%
  • Sleep 22%
• 2021

  2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis

  North American Imaging in Multiple Sclerosis Cooperative MRI guidelines working group, Magnetic Resonance Imaging in Multiple Sclerosis study group & Consortium of Multiple Sclerosis Centres, Aug 2021, In: The Lancet Neurology. 20, 8, p. 653-670 18 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Multiple Sclerosis 100%
  • Gadolinium 24%
  • Contrast Media 20%
  • Magnetic Resonance Imaging 15%
  • Guidelines 14%

• Association of Spectral-Domain OCT With Long-term Disability Worsening in Multiple Sclerosis

  Lambe, J., Fitzgerald, K. C., Murphy, O. C., Filippatou, A. G., Sotirchos, E. S., Kalaitzidis, G., Vasileiou, E., Pellegrini, N., Ogbuokiri, E., Toliver, B., Luciano, N. J., Davis, S., Fioravante, N., Kwakyi, O., Risher, H., Crainiceanu, C. M., Prince, J. L., Newsome, S. D., Mowry, E. M., Saidha, S., & 1 othersCalabresi, P. A., Apr 20 2021, In: Neurology. 96, 16, p. E2058-E2069

  Research output: Contribution to journal › Article › peer-review

  • Multiple Sclerosis 100%
  • Optical Coherence Tomography 97%
  • Ganglia 78%
  • Visual Acuity 27%
  • Linear Models 25%

• Brain and Muscle Metabolic Changes by FDG-PET in Stiff Person Syndrome Spectrum Disorders

  Wang, Y., Sadaghiani, M. S., Tian, F., Fitzgerald, K. C., Solnes, L. & Newsome, S. D., Sep 17 2021, In: Frontiers in Neurology. 12, 692240.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Stiff-Person Syndrome 100%
  • Positron-Emission Tomography 59%
  • Cerebellar Ataxia 39%
  • Muscles 38%
  • Brain 31%

• Consensus Curriculum for Fellowship Training in Multiple Sclerosis and Neuroimmunology

  Hua, L. H., Obeidat, A. Z., Amezcua, L., Cohen, J. A., Costello, K., Dunn, J., Gelfand, J. M., Goldman, M. D., Hopkins, S., Jeffery, D., Krieger, S., Newsome, S. D., Shah, S., Sicotte, N. L., Yadav, V. & Longbrake, E. E., Aug 1 2021, In: Neurology: Clinical Practice. 11, 4, p. 352-357 6 p.

  Research output: Contribution to journal › Review article › peer-review

  • Curriculum 100%
  • Multiple Sclerosis 89%
  • Accreditation 39%
  • Workforce 32%
  • Patient Care 26%

• COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America: From the COViMS Registry

  Newsome, S. D., Cross, A. H., Fox, R. J., Halper, J., Kanellis, P., Bebo, B., Li, D., Cutter, G. R., Rammohan, K. W. & Salter, A., Sep 24 2021, In: Neurology: Neuroimmunology and NeuroInflammation. 8, 5, e1057.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Myelin-Oligodendrocyte Glycoprotein 100%
  • Neuromyelitis Optica 93%
  • Coronavirus 87%
  • North America 73%
  • Registries 54%

• Defining the Expanding Clinical Spectrum of Pediatric-Onset Stiff Person Syndrome

  Yeshokumar, A. K., Sun, L. R. & Newsome, S. D., Jan 2021, In: Pediatric Neurology. 114, p. 11-15 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Stiff-Person Syndrome 100%
  • Pediatrics 41%
  • Primary Dysautonomias 31%
  • Carboxy-Lyases 28%
  • Cranial Nerve Diseases 27%

• Early Aggressive Treatment Approaches for Multiple Sclerosis

  Simpson, A., Mowry, E. M. & Newsome, S. D., Jul 2021, In: Current Treatment Options in Neurology. 23, 7, 19.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Multiple Sclerosis 100%
  • Therapeutics 18%
  • Observational Studies 16%
  • Rituximab 11%
  • Placebos 11%

• Early factors associated with later conversion to multiple sclerosis in patients presenting with isolated myelitis

  Murphy, O. C., Mukharesh, L., Salazar-Camelo, A., Pardo, C. A. & Newsome, S. D., Aug 1 2021, In: Journal of Neurology, Neurosurgery and Psychiatry. 92, 8, p. 831-838 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Myelitis 100%
  • Multiple Sclerosis 63%
  • Oligoclonal Bands 25%
  • Cerebrospinal Fluid 15%
  • Immunoglobulin G 13%

• Encephalitis and Myelitis in a Young Woman: Overlap Syndrome, Thyroiditis, and Occult Tumor From the National Multiple Sclerosis Society Case Conference Proceedings

  Zarghami Esfanhani, N., Wundes, A., Varkey, T., Lisak, R. P., Goodman, A., Graves, J., Zamvil, S. S., Frohman, E. M., Frohman, T. C. & Newsome, S. D., Sep 22 2021, In: Neurology: Neuroimmunology and NeuroInflammation. 8, 5, e1026.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD

  PREVENT Study Group, Jun 1 2021, In: Annals of neurology. 89, 6, p. 1088-1098 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • eculizumab 100%
  • Aquaporin 4 89%
  • Immunoglobulin G 50%
  • Safety 38%
  • Recurrence 10%

• MOGAD: How it differs from and resembles other neuroinflammatory disorders

  Shahriari, M., Sotirchos, E. S., Newsome, S. D. & Yousem, D. M., Apr 2021, In: American Journal of Roentgenology. 216, 4, p. 1031-1039 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Myelin-Oligodendrocyte Glycoprotein 100%
  • Gray Matter 52%
  • Neuromyelitis Optica 46%
  • Optic Nerve 35%
  • White Matter 31%
  1 Scopus citations

• Ocular Motor and Vestibular Characteristics of Antiglutamic Acid Decarboxylase-Associated Neurologic Disorders

  Wang, Y., Tourkevich, R., Bosley, J., Gold, D. R. & Newsome, S. D., Dec 1 2021, In: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 41, 4, p. e665-e671

  Research output: Contribution to journal › Article › peer-review

  • Carboxy-Lyases 100%
  • Nervous System Diseases 69%
  • Stiff-Person Syndrome 58%
  • Acids 56%
  • Eye 45%

• Outcomes and Risk Factors Associated with SARS-CoV-2 Infection in a North American Registry of Patients with Multiple Sclerosis

  Salter, A., Fox, R. J., Newsome, S. D., Halper, J., Li, D. K. B., Kanellis, P., Costello, K., Bebo, B., Rammohan, K., Cutter, G. R. & Cross, A. H., Jun 2021, In: JAMA Neurology. 78, 6, p. 699-708 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Multiple Sclerosis 59%
  • Registries 53%
  • Odds Ratio 32%
  • Infections 32%
  8 Scopus citations

• Safety evaluation of shorter infusion for ocrelizumab in a substudy of the Phase IIIb CHORDS trial

  Bermel, R. A., Waubant, E., Pardo, G., Bass, A., Repovic, P., Newsome, S., Lindsey, J. W., Kile, D., Pradhan, A., Musch, B. & Zabeti, A., Mar 2021, In: Annals of Clinical and Translational Neurology. 8, 3, p. 711-715 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • ocrelizumab 100%
  • Safety 32%
  • Relapsing-Remitting Multiple Sclerosis 17%
  • Therapeutics 4%